Table 1.
AJCC Stage
|
P valuea | |||
---|---|---|---|---|
T1aN0M0 | T1bN0M0 | All others (T1cN0, Stage II–III) | ||
| ||||
N | 519 | 1,168 | 4,416 | |
| ||||
Age at diagnosis | P<0.0001 | |||
≤39 | 5 (1.0%) | 13 (1.1%) | 208 (4.7%) | |
40–49 | 53 (10.2%) | 96 (8.2%) | 622 (14.1%) | |
≥50 | 461 (88.8%) | 1,059 (90.7%) | 3,586 (81.2%) | |
| ||||
Tumor Grade | P<0.0001 | |||
Well diff | 255 (49.1%) | 498 (42.6%) | 928 (21.0%) | |
Moderately diff | 198 (38.2%) | 469 (40.2%) | 1,808 (41.0%) | |
Poorly diff | 56 (10.8%) | 184 (15.8%) | 1,598 (36.2%) | |
Unknown | 10 (1.9%) | 17 (1.4%) | 82 (1.8%) | |
| ||||
Histology | P<0.0001 | |||
Ductal | 447 (86.1) | 1,023 (87.6%) | 3,684 (83.4%) | |
Lobular | 36 (6.9) | 78 (6.7%) | 485 (11.0%) | |
Other | 36 (6.9) | 67 (5.7%) | 247 (5.6%) |
Abbreviations: AJCC = American Joint Committee on Cancer; diff = differentiated
Calculated using χ2 test, “unknown” categories not included.